Not available
Quote | Esperion Therapeutics Inc. (NASDAQ:ESPR)
Last: | $2.43 |
---|---|
Change Percent: | -0.82% |
Open: | $2.45 |
Close: | $2.43 |
High: | $2.5 |
Low: | $2.365 |
Volume: | 2,879,238 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Esperion Therapeutics Inc. (NASDAQ:ESPR)
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
Message Board Posts | Esperion Therapeutics Inc. (NASDAQ:ESPR)
Subject | By | Source | When |
---|---|---|---|
ESPERION: REVOLUTIONIZING THE PHARMA INDUSTRY$ESPRExcited to share an article about Esperion Therape | 07/15/2024 9:26:15 AM | ||
What do you make of this? | Johnny_C | investorshub | 06/22/2023 5:05:11 AM |
ESPR - B of A Securities Upgrades Esperion | findit | investorshub | 06/15/2023 12:31:13 PM |
$ESPR what do you make of this data? | keepemcloser | investorshub | 06/14/2023 1:16:55 AM |
What do you make of this? | Johnny_C | investorshub | 06/13/2023 1:16:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
ANN ARBOR, Mich., July 25, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2024 financial results before the market opens on Monday, August 12, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financi...
ANN ARBOR, Mich., July 24, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the BTIG Biotech Conference on Monday, August 5, 2024, at 4 p.m. ET. Esperion Therapeutics At Esperion, we discover, develop, and commercialize innovat...
– Targeted Campaign Reaches Patients at Risk for Heart Attack or Heart Procedures Because of High LDL Cholesterol (LDL-C) – – Animated Characters Are a Visual Representation of An Unseen Risk “Lurking” In Patients’ Artery Walls &...